Back
L'Oreal SA Vs. Aligos Therapeutics Industry Stock Comparison
Sell
6
LRLCF
L'Oreal SA
Last Price:
$341.68
Seasonality Move:
3.44%
Buy
69
ALGS
Aligos Therapeutics
Last Price:
$43.44
Seasonality Move:
-17.17%
Sell
6
L'Oreal SA (LRLCF)
is a Sell
Is L'Oreal SA a Buy, Sell or Hold?
-
The current L'Oreal SA [LRLCF] share price is $341.68. The Score for LRLCF is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
-
LRLCF is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
69
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $43.42. The Score for ALGS is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LRLCF Stock Price Chart
What is L'Oreal SA's stock price today?
-
The L'Oreal SA share price today is $341.68Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LRLCF is experiencing selling pressure, which indicates risk of future bearish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $43.42Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
LRLCF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.96 | Sell |
Relative Strength Index (14 RSI): | 40.45 | Sell |
Chaikin Money Flow: | -3831 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (346.43 - 360.25) | Sell |
Bollinger Bands (100): | (355.21 - 425.61) | Sell |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.14 | Buy |
Relative Strength Index (14 RSI): | 74.33 | Buy |
Chaikin Money Flow: | 210748 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.82 - 40.1) | Buy |
Bollinger Bands (100): | (6.77 - 28.07) | Buy |
LRLCF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 349.44 | Sell |
20-day SMA: | 354.82 | Sell |
50-day SMA: | 358.25 | Sell |
200-day SMA: | 425.61 | Sell |
8-day EMA: | 347.98 | Sell |
20-day EMA: | 351.91 | Sell |
50-day EMA: | 363.65 | Sell |
200-day EMA: | 409.12 | Sell |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.78 | Buy |
20-day SMA: | 36.11 | Buy |
50-day SMA: | 23.97 | Buy |
200-day SMA: | 16.97 | Buy |
8-day EMA: | 40.32 | Buy |
20-day EMA: | 35.95 | Buy |
50-day EMA: | 27.43 | Buy |
200-day EMA: | 19.22 | Buy |
L'Oreal SA Earnings Growth & LRLCF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.
L'Oreal SA Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |